CNS lymphoma · 2 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
High-dose Cytarabine monotherapy (HiDAC) Variant #01 | — | R 26 364 | — | ~5.2 mo | — | — | — | 1 |
Methotrexate monotherapy Partial | — | — | — | ~2.6 mo | ~6.7 mo | — | — | 10 |
2 of 2 regimens shown